167 related articles for article (PubMed ID: 16886621)
1. Monoclonal antibody to human esophageal cancer endothelium inhibits angiogenesis and tumor growth.
Zhang Y; Ran Y; Yu L; Hu H; Zhou Z; Sun L; Lou J; Yang Z
Anticancer Res; 2006; 26(4B):2963-70. PubMed ID: 16886621
[TBL] [Abstract][Full Text] [Related]
2. Human esophageal cancer endothelial cells increase tumor growth by incorporating with mouse endothelium.
Hu H; Zhang Y; Ran Y; Zhou Z; Yu L; Lou J; Yang Z
Cancer Lett; 2007 Jul; 252(1):123-30. PubMed ID: 17276590
[TBL] [Abstract][Full Text] [Related]
3. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats.
Tei K; Kawakami-Kimura N; Taguchi O; Kumamoto K; Higashiyama S; Taniguchi N; Toda K; Kawata R; Hisa Y; Kannagi R
Cancer Res; 2002 Nov; 62(21):6289-96. PubMed ID: 12414659
[TBL] [Abstract][Full Text] [Related]
4. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody directed against a human cell membrane antigen prevents cell substrate adhesion and tumor invasion.
De Potter CR; Schelfhout AM; De Smet FH; Van Damme S; de Ridder L; Dhont E; van Emmelo J
Am J Pathol; 1994 Jan; 144(1):95-103. PubMed ID: 8291615
[TBL] [Abstract][Full Text] [Related]
6. [Preparation of functional antibodies targeting tumor endothelia for the treatment of hepatic carcinoma].
Hu H; Ran YL; Yu L; Zhou Z; Lou JN; Yang ZH
Ai Zheng; 2007 May; 26(5):453-7. PubMed ID: 17672931
[TBL] [Abstract][Full Text] [Related]
7. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
8. A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model.
Yoneyama S; Okaji Y; Tsuno NH; Kawai K; Yamashita H; Tsuchiya T; Yamada J; Sunami E; Osada T; Kitayama J; Takahashi K; Nagawa H
Eur J Surg Oncol; 2007 Dec; 33(10):1191-8. PubMed ID: 17314028
[TBL] [Abstract][Full Text] [Related]
9. A novel human monoclonal antibody derived from tumor-infiltrating lymphocytes in lung cancer inhibits cancer cell growth with morphological changes.
Aoki M; Saikawa Y; Hosokawa S; Fukuda K; Kumai K; Kubota T; Yoshida M; Otani Y; Kitajima M
Anticancer Res; 2005; 25(6B):3791-8. PubMed ID: 16309165
[TBL] [Abstract][Full Text] [Related]
10. Expression of non-mast cell histidine decarboxylase in tumor-associated microvessels in human esophageal squamous cell carcinomas.
Li Z; Liu J; Tang F; Liu Y; Waldum HL; Cui G
APMIS; 2008 Dec; 116(12):1034-42. PubMed ID: 19133005
[TBL] [Abstract][Full Text] [Related]
11. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.
Suzuki N; Aoki D; Tamada Y; Susumu N; Orikawa K; Tsukazaki K; Sakayori M; Suzuki A; Fukuchi T; Mukai M; Kojima-Aikawa K; Ishida I; Nozawa S
Gynecol Oncol; 2004 Nov; 95(2):290-8. PubMed ID: 15491748
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.
Vosseler S; Mirancea N; Bohlen P; Mueller MM; Fusenig NE
Cancer Res; 2005 Feb; 65(4):1294-305. PubMed ID: 15735015
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice.
Ran S; He J; Huang X; Soares M; Scothorn D; Thorpe PE
Clin Cancer Res; 2005 Feb; 11(4):1551-62. PubMed ID: 15746060
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of stefin A in human esophageal squamous cell carcinoma cells inhibits tumor cell growth, angiogenesis, invasion, and metastasis.
Li W; Ding F; Zhang L; Liu Z; Wu Y; Luo A; Wu M; Wang M; Zhan Q; Liu Z
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8753-62. PubMed ID: 16361563
[TBL] [Abstract][Full Text] [Related]
15. [Establishment and application of engrafted tumor models with humanized tumor blood vessel].
Ran YL; Zhong X; Hu H; Yu L; Lou JN; Yang ZH
Ai Zheng; 2006 Nov; 25(11):1323-8. PubMed ID: 17094895
[TBL] [Abstract][Full Text] [Related]
16. Involvement of H type 1 carbohydrate antigen in cell adhesion to vascular endothelial cells of human endometrial cancer.
Sakuma Y; Kubushiro K; Tsukazaki K; Nozawa S
Anticancer Res; 2003; 23(2B):1277-82. PubMed ID: 12820383
[TBL] [Abstract][Full Text] [Related]
17. [A monoclonal antibody reactive with human squamous cell carcinoma of the esophagus].
Tomita Y
Nihon Geka Gakkai Zasshi; 1994 Jul; 95(7):425-34. PubMed ID: 7520969
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis.
Burden RE; Gormley JA; Jaquin TJ; Small DM; Quinn DJ; Hegarty SM; Ward C; Walker B; Johnston JA; Olwill SA; Scott CJ
Clin Cancer Res; 2009 Oct; 15(19):6042-51. PubMed ID: 19789302
[TBL] [Abstract][Full Text] [Related]
19. Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin 2.
Epstein AL; Khawli LA; Hornick JL; Taylor CR
Cancer Res; 1995 Jun; 55(12):2673-80. PubMed ID: 7780984
[TBL] [Abstract][Full Text] [Related]
20. A novel anti-human syndecan-1 (CD138) monoclonal antibody 4B3: characterization and application.
Sun WP; Wang FM; Xie F; Wang GQ; Sun J; Yu GH; Qiu YH; Zhang XG
Cell Mol Immunol; 2007 Jun; 4(3):209-14. PubMed ID: 17601375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
